Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant erythropoietin overdose

K R Brown1, W Carter, G E Lombardi

  • 1Department of Emergency Medicine, St Luke's Roosevelt Hospital Center New York, NY.

The American Journal of Emergency Medicine
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shocked and disappointed.

British dental journal·2020
Same author

Reassigning the CaH<sup>+</sup> 1<sup>1</sup>Σ → 2<sup>1</sup>Σ vibronic transition with CaD<sup></sup>.

The Journal of chemical physics·2017
Same author

Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study.

Addiction science & clinical practice·2017
Same author

Endotypes of difficult-to-control asthma in inner-city African American children.

PloS one·2017
Same author

Acute exposure to ergot alkaloids from endophyte-infected tall fescue does not alter absorptive or barrier function of the isolated bovine ruminal epithelium.

Animal : an international journal of animal bioscience·2015
Same author

Tunable spin-spin interactions and entanglement of ions in separate potential wells.

Nature·2014

This case report details a 62-year-old man who self-administered recombinant human erythropoietin (rHuEpo) without anemia, leading to dangerous polycythemia and severe health complications. It highlights the critical need to consider rHuEpo abuse in unexplained polycythemia diagnoses.

Area of Science:

  • Endocrinology
  • Hematology
  • Toxicology

Background:

  • Recombinant human erythropoietin (rHuEpo) is a therapeutic protein used to treat anemia.
  • Its misuse for non-medical purposes, such as performance enhancement or illicit self-administration, is a growing concern.
  • Documented cases of deliberate self-administration of rHuEpo in individuals without anemia are rare.

Observation:

  • A 62-year-old male healthcare worker was found to have dangerously elevated hematocrit levels.
  • He had been secretly self-administering rHuEpo.
  • The patient presented with worsening hypertension, exacerbated chronic lung disease, and new-onset angina.

Findings:

  • The patient's polycythemia resulted from rHuEpo misuse.
  • Medical interventions included mechanical ventilation, hydration, and phlebotomy.

Related Experiment Videos

  • The misuse led to significant cardiovascular and respiratory complications.

    • Implications:

    • Erythropoietin abuse should be considered in the differential diagnosis of unexplained polycythemia.
    • This case underscores the potential for abuse of biological growth factors.
    • Healthcare professionals must be vigilant for the misuse of performance-enhancing biological agents.